Givaudan Q1 sales
This article was originally published in The Rose Sheet
Executive Summary
Fine fragrance sales showed signs of recovery with double-digit local currency growth in the first quarter on "successful introduction of new business," Geneva, Switzerland fragrance and flavors supplier reports in April 11 1sales release. Consumer Products business began third consecutive year of positive growth with sales increasing high single digits in local currencies. Fragrance division sales, however, fell 2.6% to $203.9 mil. in Swiss Francs (CHF1=$.72). Fragrance ingredients business unit experienced "marginal" growth in the quarter. Declining sales in the segment are anticipated in the coming months due to the phase out of sunscreen filters, Givaudan says. Consolidated net sales for the first quarter increased 7.9% to $492.6 mil...
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.